260 related articles for article (PubMed ID: 27456754)
21. TSLC1 expression discriminates cutaneous melanomas from dysplastic nevi.
You Y; Wang SH; Zhang JF; Zheng SY
Melanoma Res; 2012 Dec; 22(6):430-5. PubMed ID: 23047161
[TBL] [Abstract][Full Text] [Related]
22. Significant melanocytic lesions in infancy, childhood, and adolescence.
Hoss DM; Grant-Kels JM
Dermatol Clin; 1986 Jan; 4(1):29-44. PubMed ID: 3521978
[TBL] [Abstract][Full Text] [Related]
23. IMP-3 EXPRESSION IN BENIGN MELANOCYTIC NEVI, DYSPLASTIC NEVI AND MALIGNANT MELANOMA: PRELIMINARY FINDINGS IN BULGARIAN PATIENTS.
Chokoeva AA; Ananiev J; Wollina U; Tana C; Lotti T; Cardoso JC; Tchernev G
J Biol Regul Homeost Agents; 2015; 29(3):695-9. PubMed ID: 26403409
[TBL] [Abstract][Full Text] [Related]
24. Diagnosing and treating congenital melanocytic nevus simulating malignant melanoma.
Kovach R; Hochberg J; Ardenghy M; Deangelis R; Welton W
W V Med J; 1996; 92(4):191-3. PubMed ID: 8772404
[TBL] [Abstract][Full Text] [Related]
25. C-kit expression of melanocytic neoplasm and association with clinicopathological parameters and anatomic locations in Chinese people.
Lin YC; Chang YM; Ho JY; Lin HC; Tsai YM; Chiang CP; Wang WM; Gao HW
Am J Dermatopathol; 2013 Jul; 35(5):569-75. PubMed ID: 23221472
[TBL] [Abstract][Full Text] [Related]
26. Proliferative Nodules vs Melanoma Arising in Giant Congenital Melanocytic Nevi During Childhood.
Vergier B; Laharanne E; Prochazkova-Carlotti M; de la Fouchardière A; Merlio JP; Kadlub N; Avril MF; Bodemer C; Lacoste C; Boralevi F; Taieb A; Ezzedine K; Fraitag S
JAMA Dermatol; 2016 Oct; 152(10):1147-1151. PubMed ID: 27486690
[TBL] [Abstract][Full Text] [Related]
27. 5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi.
Uchiyama R; Uhara H; Uchiyama A; Ogawa E; Takazawa Y; Ashida A; Koga H; Hayashi K; Kiniwa Y; Okuyama R
J Dermatol Sci; 2014 Feb; 73(2):161-3. PubMed ID: 24169492
[No Abstract] [Full Text] [Related]
28. Dysplastic nevi.
Farber MJ; Heilman ER; Friedman RJ
Dermatol Clin; 2012 Jul; 30(3):389-404. PubMed ID: 22800547
[TBL] [Abstract][Full Text] [Related]
29. Genomic Characterization of Dysplastic Nevi Unveils Implications for Diagnosis of Melanoma.
Melamed RD; Aydin IT; Rajan GS; Phelps R; Silvers DN; Emmett KJ; Brunner G; Rabadan R; Celebi JT
J Invest Dermatol; 2017 Apr; 137(4):905-909. PubMed ID: 27890785
[TBL] [Abstract][Full Text] [Related]
30. Expression of NM23 protein in acquired melanocytic nevi, malignant melanoma and metastases of malignant melanoma: an immunohistological assessment in human skin.
Reichrath J; Seyfried P; Braun R; Müller SM; Baum HP; Bahmer FA
Dermatology; 1997; 194(2):136-9. PubMed ID: 9094461
[TBL] [Abstract][Full Text] [Related]
31. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes.
Ko JS; Matharoo-Ball B; Billings SD; Thomson BJ; Tang JY; Sarin KY; Cai E; Kim J; Rock C; Kimbrell HZ; Flake DD; Warf MB; Nelson J; Davis T; Miller C; Rushton K; Hartman AR; Wenstrup RJ; Clarke LE
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1107-1113. PubMed ID: 28377414
[No Abstract] [Full Text] [Related]
33. De novo melanoma and melanoma arising from pre-existing nevus: in vivo morphologic differences as evaluated by confocal microscopy.
Longo C; Rito C; Beretti F; Cesinaro AM; Piñeiro-Maceira J; Seidenari S; Pellacani G
J Am Acad Dermatol; 2011 Sep; 65(3):604-614. PubMed ID: 21715047
[TBL] [Abstract][Full Text] [Related]
34. Melanocytic nevi simulant of melanoma with medicolegal relevance.
Massi G
Virchows Arch; 2007 Sep; 451(3):623-47. PubMed ID: 17653760
[TBL] [Abstract][Full Text] [Related]
35. A hypothesis incorporating the histologic characteristics of dysplastic nevi into the normal biological development of melanocytic nevi.
Piepkorn M
Arch Dermatol; 1990 Apr; 126(4):514-8. PubMed ID: 2321996
[TBL] [Abstract][Full Text] [Related]
36. Metastatic melanoma in association with a giant congenital melanocytic nevus in an adult: controversial CGH findings.
Machan S; Molina-Ruiz AM; Fernández-Aceñero MJ; Encabo B; LeBoit P; Bastian BC; Requena L
Am J Dermatopathol; 2015 Jun; 37(6):487-94. PubMed ID: 25062263
[TBL] [Abstract][Full Text] [Related]
37. Lack of p53 mutations and loss of heterozygosity in non-cultured human melanocytic lesions.
Papp T; Jafari M; Schiffmann D
J Cancer Res Clin Oncol; 1996; 122(9):541-8. PubMed ID: 8781568
[TBL] [Abstract][Full Text] [Related]
38. A comparative study of proliferative nodules and lethal melanomas in congenital nevi from children.
Yélamos O; Arva NC; Obregon R; Yazdan P; Wagner A; Guitart J; Gerami P
Am J Surg Pathol; 2015 Mar; 39(3):405-15. PubMed ID: 25517953
[TBL] [Abstract][Full Text] [Related]
39. Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin.
Gerami P; Alsobrook JP; Palmer TJ; Robin HS
J Am Acad Dermatol; 2014 Aug; 71(2):237-44. PubMed ID: 24906614
[TBL] [Abstract][Full Text] [Related]
40. Mitotically active proliferative nodule arising in a giant congenital melanocytic nevus: a diagnostic pitfall.
Nguyen TL; Theos A; Kelly DR; Busam K; Andea AA
Am J Dermatopathol; 2013 Feb; 35(1):e16-21. PubMed ID: 23348144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]